Gene · 710
Papers4,575
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
661 to 680 of 4,575
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Immune cells drive new immunomodulatory therapies for myocardial infarction: From basic to clinical translation. | Front Immunol | 2023 | 36761726 | PubTator, text mining | PubMed |
| The brain reacting to COVID-19: analysis of the cerebrospinal fluid proteome, RNA and inflammation. | J Neuroinflammation | 2023 | 36759861 | PubTator, text mining | PubMed |
| Identification of biomarkers to stratify response to B-cell-targeted therapies in systemic lupus erythematosus: an exploratory analysis of a randomised controlled trial. | Lancet Rheumatol | 2023 | 36756239 | PubTator, text mining | PubMed |
| Interaction of Cardiovascular Nonmodifiable Risk Factors, Comorbidities and Comedications With Ischemia/Reperfusion Injury and Cardioprotection by Pharmacological Treatments and Ischemic Conditioning. | Pharmacol Rev | 2023 | 36753049 | PubTator, text mining | PubMed |
| Testosterone therapy increases the anticoagulant potential in men with opioid-induced hypogonadism: a randomized, placebo-controlled study. | Endocr Connect | 2023 | 36752832 | PubTator, text mining | PubMed |
| Addition of Losartan to FOLFIRINOX and Chemoradiation Reduces Immunosuppression-Associated Genes, Tregs, and FOXP3+ Cancer Cells in Locally Advanced Pancreatic Cancer. | Clin Cancer Res | 2023 | 36749873 | PubTator, text mining | PubMed |
| Nonepisodic angioedema with eosinophilia after COVID-19 vaccination: a case successfully treated with reslizumab. | Allergy Asthma Clin Immunol | 2023 | 36732834 | PubTator, text mining | PubMed |
| C1-inhibitor/C1-inhibitor antibody complexes in acquired angioedema due to C1-inhibitor deficiency. | Orphanet J Rare Dis | 2023 | 36726161 | PubTator, text mining | PubMed |
| Measuring the multifaceted roles of mucin-domain glycoproteins in cancer. | Adv Cancer Res | 2023 | 36725114 | PubTator, text mining | PubMed |
| Mass spectrometry based biomarkers for early detection of HCC using a glycoproteomic approach. | Adv Cancer Res | 2023 | 36725111 | PubTator, text mining | PubMed |
| Sequential genome-wide CRISPR-Cas9 screens identify genes regulating cell-surface expression of tetraspanins. | Cell Rep | 2023 | 36724073 | PubTator, text mining | PubMed |
| Ethnic differences in complement system biomarkers and their association with metabolic health in men of Black African and White European ethnicity. | Clin Exp Immunol | 2023 | 36722378 | PubTator, text mining | PubMed |
| The contribution of the alternative pathway in complement activation on cell surfaces depends on the strength of classical pathway initiation. | Clin Transl Immunology | 2023 | 36721662 | PubTator, text mining | PubMed |
| Combined anti-C1-INH and radiotherapy against glioblastoma. | BMC Cancer | 2023 | 36717781 | PubTator, text mining | PubMed |
| Novel insights in the clinical management of hyperimmune patients before and after transplantation. | Curr Res Immunol | 2023 | 36714552 | PubTator, text mining | PubMed |
| C1 inhibitor deficiency enhances contact pathway-mediated activation of coagulation and venous thrombosis. | Blood | 2023 | 36701760 | PubTator, text mining | PubMed |
| Transcriptional responses define dysregulated immune activation in Hepatitis C (HCV)-naïve recipients of HCV-infected donor kidneys. | PLoS One | 2023 | 36701416 | PubTator, text mining | PubMed |
| A "best-in-class" systemic biomarker predictor of clinically relevant knee osteoarthritis structural and pain progression. | Sci Adv | 2023 | 36696492 | PubTator, text mining | PubMed |
| Peripheral blood mononuclear cell tissue factor (F3 gene) transcript levels and circulating extracellular vesicles are elevated in severe coronavirus 2019 (COVID-19) disease. | J Thromb Haemost | 2023 | 36696180 | PubTator, text mining | PubMed |
| Type 2 diabetes candidate genes, including PAX5, cause impaired insulin secretion in human pancreatic islets. | J Clin Invest | 2023 | 36656641 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/710/papers?page=34